Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients . J. Can. Res. Updates [Internet]. 2012 Jan. 28 [cited 2025 Oct. 10];1(1): 44-48. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/372